Literature DB >> 3828530

Sardinian delta beta zero-thalassemia: a further example of a C to T substitution at position -196 of the A gamma globin gene promoter.

S Ottolenghi, B Giglioni, A Pulazzini, P Comi, C Camaschella, A Serra, A Guerrasio, G Saglio.   

Abstract

Selective overexpression (50- to 100-fold) in adult erythroid cells of either G gamma or A gamma fetal globin gene is observed in hereditary conditions known as delta beta zero-thalassemia and hereditary persistence of fetal hemoglobin (HPFH). Recently, a C----T change at position -196 of an overexpressed A gamma globin gene from an Italian HPFH was hypothesized, on the basis of indirect evidence, to represent the cause of the functional defect. We now show that the same mutation is present in a different overexpressed A gamma-globin gene from a Sardinian patient with a different syndrome (delta beta zero-thalassemia). The Sardinian A gamma globin gene differs from both the HPFH and the normal A gamma globin gene at nucleotide 1,560 in the noncoding portion of the third exon, where an A is deleted. In addition, the mutant -196 A gamma-globin gene is linked to a normal beta globin gene in HPFH, and to a beta-thalassemic gene (beta 39CAG----TAG) in delta beta zero-thalassemia. These data strengthen the suggestion that -196 mutation is causally linked to the abnormal phenotype and raise the question of whether the same or multiple mutational events are responsible for the appearance of the -196 mutation in different syndromes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3828530

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  A frequent A gamma-hereditary persistence of fetal hemoglobin in northern Sardinia: its molecular basis and hematologic phenotype in heterozygotes and compound heterozygotes with beta-thalassemia.

Authors:  S Ottolenghi; C Camaschella; P Comi; B Giglioni; M Longinotti; L Oggiano; F Dore; G Sciarratta; G Ivaldi; G Saglio
Journal:  Hum Genet       Date:  1988-05       Impact factor: 4.132

2.  The effects of HPFH mutations in the human gamma-globin promoter on binding of ubiquitous and erythroid specific nuclear factors.

Authors:  R Mantovani; N Malgaretti; S Nicolis; A Ronchi; B Giglioni; S Ottolenghi
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

3.  Analyses of linked beta-globin genes suggest that nondeletion forms of hereditary persistence of fetal hemoglobin are bona fide switching mutants.

Authors:  J E Metherall; F P Gillespie; B G Forget
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

4.  Hemoglobin F production in heterocellular hereditary persistence of fetal hemoglobin and its linkage to the beta globin gene complex.

Authors:  J A Donald; A Lammi; R J Trent
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

5.  A protein factor binding to an octamer motif in the gamma-globin promoter disappears upon induction of differentiation and hemoglobin synthesis in K562 cells.

Authors:  R Mantovani; N Malgaretti; B Giglioni; P Comi; N Cappellini; S Nicolis; S Ottolenghi
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

6.  The T----C substitution at -198 of the A gamma-globin gene associated with the British form of HPFH generates overlapping recognition sites for two DNA-binding proteins.

Authors:  K D Fischer; J Nowock
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

7.  Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.

Authors:  Manuela Uda; Renzo Galanello; Serena Sanna; Guillaume Lettre; Vijay G Sankaran; Weimin Chen; Gianluca Usala; Fabio Busonero; Andrea Maschio; Giuseppe Albai; Maria Grazia Piras; Natascia Sestu; Sandra Lai; Mariano Dei; Antonella Mulas; Laura Crisponi; Silvia Naitza; Isadora Asunis; Manila Deiana; Ramaiah Nagaraja; Lucia Perseu; Stefania Satta; Maria Dolores Cipollina; Carla Sollaino; Paolo Moi; Joel N Hirschhorn; Stuart H Orkin; Gonçalo R Abecasis; David Schlessinger; Antonio Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-01       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.